These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37768405)

  • 1. Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature.
    Vermeer E; Hebing RCF; van de Meeberg MM; Lin M; de Meij TGJ; Struys EA; Jansen G; Nurmohamed MT; Ćalasan MB; de Jonge R
    Curr Rheumatol Rep; 2023 Dec; 25(12):276-284. PubMed ID: 37768405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis.
    van de Meeberg MM; Hebing RCF; Nurmohamed MT; Fidder HH; Heymans MW; Bouma G; de Bruin-Weller MS; Tekstra J; van den Bemt B; de Jonge R; Bulatović Ćalasan M
    Br J Clin Pharmacol; 2023 Jan; 89(1):61-79. PubMed ID: 36326810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms.
    Cipriani P; Ruscitti P; Carubbi F; Liakouli V; Giacomelli R
    Clin Ther; 2014 Mar; 36(3):427-35. PubMed ID: 24612941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration.
    Bianchi G; Caporali R; Todoerti M; Mattana P
    Adv Ther; 2016 Mar; 33(3):369-78. PubMed ID: 26846283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial.
    Hebing RC; Lin M; Bulatovic Calasan M; Muller IB; Mahmoud S; Heil S; Struys EA; van den Bemt BJ; Twisk JW; Lems W; Nurmohamed MT; Jansen G; de Jonge R
    Ann Rheum Dis; 2023 Apr; 82(4):460-467. PubMed ID: 36543526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis.
    Tuková J; Chládek J; Nemcová D; Chládková J; Dolezalová P
    Clin Exp Rheumatol; 2009; 27(6):1047-53. PubMed ID: 20149329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration.
    Schiff MH; Jaffe JS; Freundlich B
    Ann Rheum Dis; 2014 Aug; 73(8):1549-51. PubMed ID: 24728329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
    Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
    Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
    Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
    Pichlmeier U; Heuer KU
    Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study.
    Hawwa AF; AlBawab A; Rooney M; Wedderburn LR; Beresford MW; McElnay JC
    Arthritis Res Ther; 2015 Oct; 17():295. PubMed ID: 26493320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate response or intolerability to oral methotrexate: Is it optimal to switch to subcutaneous methotrexate prior to considering therapy with biologics?
    Yadlapati S; Efthimiou P
    Rheumatol Int; 2016 May; 36(5):627-33. PubMed ID: 26936262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis.
    Schiff MH; Sadowski P
    Rheumatol Int; 2017 Feb; 37(2):213-218. PubMed ID: 28012023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
    Braun J; Kästner P; Flaxenberg P; Währisch J; Hanke P; Demary W; von Hinüber U; Rockwitz K; Heitz W; Pichlmeier U; Guimbal-Schmolck C; Brandt A;
    Arthritis Rheum; 2008 Jan; 58(1):73-81. PubMed ID: 18163521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study.
    Branco JC; Barcelos A; de Araújo FP; Sequeira G; Cunha I; Patto JV; Oliveira M; Mateus MP; Couto M; Nero P; Pinto P; Monteiro P; Castelão W; Félix J; Ferreira D; Almeida J; Silva MJ
    Adv Ther; 2016 Jan; 33(1):46-57. PubMed ID: 26724937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of fluorescence polarization immunoassay for determination of methotrexate-polyglutamates in rheumatoid arthritis patients.
    Hayashi H; Fujimaki C; Tsuboi S; Matsuyama T; Daimon T; Itoh K
    Tohoku J Exp Med; 2008 May; 215(1):95-101. PubMed ID: 18509240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis.
    Hazlewood GS; Thorne JC; Pope JE; Lin D; Tin D; Boire G; Haraoui B; Hitchon CA; Keystone EC; Jamal S; Bykerk VP;
    Ann Rheum Dis; 2016 Jun; 75(6):1003-8. PubMed ID: 25979945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn's disease: a cross-sectional study.
    van de Meeberg MM; Seinen ML; Fidder HH; Lin M; Oldenburg B; de Boer NK; Bouma G; de Jonge R; Bulatović Ćalasan M;
    BMC Gastroenterol; 2022 Jul; 22(1):365. PubMed ID: 35907797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.
    Emery P; Fleischmann RM; Moreland LW; Hsia EC; Strusberg I; Durez P; Nash P; Amante EJ; Churchill M; Park W; Pons-Estel BA; Doyle MK; Visvanathan S; Xu W; Rahman MU
    Arthritis Rheum; 2009 Aug; 60(8):2272-83. PubMed ID: 19644849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.